Published recall report · ImpurityUpdated · 6 yr 9 mo ago
Amneal Pharmaceuticals, Inc. recall: Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.
Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.
- Producer
- Amneal Pharmaceuticals, Inc.
- Brand
- RANITIDINE
0353746253019
0353746254016
More detail
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.